Dr. Amy Kang

Dr. Amy Kang

Assistant Professor, Pharmacy Practice
School of Pharmacy
Expertise: Infectious Diseases; Antibiotic Resistance; Antibiotic Stewardship; Outcomes Research;
Office Location: Rinker Health Science Campus 94-226
Phone: (714) 516-5717
Education:
University of California, Los Angeles, Bachelor of Science
Loma Linda University, Doctor of Pharmacy

Biography

Dr. Amy Kang joined CUSP on July 1, 2018 as an assistant professor of pharmacy practice.  Dr. Kang received her Bachelors of Science in Microbiology, Immunology, and Molecular Genetics from University of California Los Angeles (UCLA), and she earned her Doctor of Pharmacy at Loma Linda University (LLU) School of Pharmacy where she received numerous honors, including the American Pharmacists Association (APhA) Foundation Award—Robert D. Gibson Scholarship and the President's Award, highest honor given among graduates, for her exceptional leadership and top academic performance. 

She completed her Post-graduate Year 1 (PGY-1) Pharmacy Practice Residency training at University of California San Francisco (UCSF) Medical Center, where she served as a chief resident.  During her tenure at UCSF, she received the Dean's Apple Teaching Award for her outstanding teaching efforts in the School of Pharmacy.  After her PGY-1 training, she pursued a PGY-2 training in Infectious Diseases at University of Southern California (USC), primarily practicing at LAC+USC Medical Center.  Throughout her residency training, Dr. Kang has been extensively involved with teaching pharmacy and medical trainees in the classroom and various clinical settings.

Dr. Kang has held numerous leadership positions at both the local and national pharmacy organizations, where she was recognized for her dedication to advance pharmacy practice.  

Research Interests:

Dr. Kang's research interests are in the areas of infectious diseases, focusing on antimicrobial use and resistance.  She is interested in identifying risk factors of patients that may respond poorly to standard therapies and optimizing antibiotic utilization for serious infections such as bacteremia and highly resistant infections including extended-spectrum beta-lactamases (ESBL) producing enterobacteriaceae.  Throughout her pharmacy career, Dr. Kang has been heavily involved in designing and conducting various clinical studies, serving as a clinical research coordinator at LLU and St. Jude Hospital.  Dr. Kang has presented her research findings at numerous conferences at the state, national, and international level.